# Impact of Hepatitis B Virus on Inflammatory Bowel Disease

> **NCT06881238** · — · RECRUITING · sponsor: **Tanta University** · enrollment: 162 (estimated)

## Conditions studied

- Inflammatory Bowel Disease (IBD)
- Hepatitis B Virus

## Interventions

- **OTHER:** History of IBD course and outcome in HBV patients

## Key facts

- **NCT ID:** NCT06881238
- **Lead sponsor:** Tanta University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-12-01
- **Primary completion:** 2025-05-30
- **Final completion:** 2025-06-10
- **Target enrollment:** 162 (ESTIMATED)
- **Last updated:** 2025-03-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06881238

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06881238, "Impact of Hepatitis B Virus on Inflammatory Bowel Disease". Retrieved via AI Analytics 2026-07-02 from https://api.ai-analytics.org/clinical/NCT06881238. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*